Figure 1.

Effects of α-conotoxin c-Vc1.1 and baclofen (bac) on stably expressed human Cav2.1 (α1A-2) or human Cav2.3c (α1E-c) channels in the presence of transiently expressed human GABABR subunits R1 and R2 (GABABR). (A and B) 50 µM baclofen inhibits Cav2.1 or Cav2.3c channel currents, whereas 200 nM c-Vc1.1 only inhibits Cav2.3c currents. Bars indicate c-Vc1.1 or baclofen application. IBa was evoked by 150-ms depolarizations to 10 mV (Cav2.3c) or 15 mV (Cav2.1), applied every 10 s from an HP of −80 mV (voltage inset). Peak current amplitudes were plotted as a function of time. Representative IBa traces (right) are shown at the times indicated by lowercase letters. Horizontal dotted line represents zero-current level. Note that Cav2.1 current inhibition by baclofen is reversible on washout (A), whereas baclofen or c-Vc1.1 irreversibly inhibits Cav2.3c currents (B). (C) 50 µM baclofen inhibits IBa in Cav2.3/GABABR cells. Experimental procedures are similar to those in A or B.

or Create an Account

Close Modal
Close Modal